SCHEMBL14979175

SCHEMBL14979175

CC(=N)c1cccnc1NC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.44
ATR Q13535 1/20 0.43
NAMPT P43490 1/20 0.41
HTT P42858 2/20 0.40
RAB9A P51151 4/20 0.39
KMT2A Q03164 3/20 0.39
NPC1 O15118 2/20 0.39
MEN1 O00255 2/20 0.39
CYP17A1 P05093 3/20 0.39
POLB P06746 1/20 0.39
CNR2 P34972 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.38
AHR P35869 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30026311 0.89 NAMPT (0.46) METAP1ATRNAMPTHTTRAB9A
SCHEMBL8984337 0.89 NAMPT (0.46) METAP1ATRNAMPTHTTRAB9A
SCHEMBL4669212 0.86 DHODH (0.51) METAP1ATRHTTRAB9AKMT2A
SCHEMBL4351188 0.84 ATR (0.56) METAP1ATRNAMPTHTTRAB9A
SCHEMBL14979177 0.84 AKT1 (0.41) METAP1ATRNAMPTHTTRAB9A
SCHEMBL14291452 0.84 ATR (0.44) METAP1ATRNAMPTHTTRAB9A
SCHEMBL29142183 0.82 METAP1 (0.46) METAP1ATRNAMPTHTTRAB9A
SCHEMBL29857768 0.82 METAP1 (0.46) METAP1ATRNAMPTHTTRAB9A
SCHEMBL14979178 0.81 METAP1 (0.39) METAP1ATRNAMPTHTTCYP17A1
SCHEMBL15266282 0.80 METAP1 (0.56) METAP1ATRNAMPTRAB9ACYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2781508-B9 NITROGEN-CONTAINING FUSED RING COMPOUNDS FOR USE AS CRTH2 ANTAGONISTS KBP BIOSCIENCES CO LTD (CN) 2019-08-21 EP disclosed
WO-2013071880-A1 NITROGEN-CONTAINING FUSED RING COMPOUNDS FOR USE AS CRTH2 ANTAGONISTS 山东亨利医药科技有限责任公司 (CN) 2013-05-23 WO disclosed